In the first quarter of 2022, Creative Biolabs launched a live webinar series to share thoughts and results from cutting-edge research with its clients and other audiences with an interest in immunotherapy. On January 21, 2022, a — webinar about next-generation nuclear localization signal (NLS)-therapeutics was held, and the recording is now available for those who are interested but missed the live event to watch again.
Dr. Jeffrey Leyton of the Université de Sherbrooke was invited to speak about his research on nuclear localization signal-therapeutics, which included an Accum™-functionalized ADC molecule, and how he improved traditional nuclear targeting approaches to optimize NLS therapeutics.
Antibody-drug conjugate (ADC) has gained a lot of attention in the last few years, thanks to a slew of worldwide strategic acquisitions and ground-breaking preclinical and clinical trial findings. It offers precision medicine for many hard-to-treat diseases like cancer, as it is at the forefront of target therapy. Creative Biolabs, a responsible CRO that has been working on immunotherapy for over a decade, continues to provide top-notch ADC solutions to researchers all around the world.
Creative Biolabs can handle one-stop ADC development projects, covering ADC component screening, synthesis, validation, and evaluation.
* Customized ADCs
* DrugLnk Products: toxins, linkers, drug-linker complexes
* Anti-Ab ADCs
* Anti-drug Abs
The services and products are backed by high-end platforms that cover every significant step of the production of an ADC candidate, including:
* Antibody design: design and engineering of monoclonal antibodies
* Synthetic chemistry: synthesize the drug-linker complex with an organic chemistry synthesis platform
* ADC manufacturing: large-scale ADC preparation
* PtLnX™: generate ADCs using a short non-cleavable linker with a Platinum core
* 3D Cell culture
Despite the fact that the world is currently affected by SARS-CoV-2 and its divergent strains, Creative Biolabs' scientists never stop moving forward, staying on task to assure timely delivery of research-use products and project results.
Visit https://www.creative-biolabs.com/adc/ to learn more about Creative Biolabs' capabilities and resources.
Creative Biolabs is a group of professionals with backgrounds in biochemistry. Creative Biolabs has built a systematic ADC-focused workflow after years of dedicated investigation, which can not only promise speedy delivery of in-stock items but also a thorough solution proposal for a custom project following detailed consultation with the experts.
Release ID: 89063139